MediciNova, Inc. (MNOV)
NASDAQ: MNOV · Real-Time Price · USD
1.420
0.00 (0.00%)
Apr 2, 2026, 12:27 PM EDT - Market open
MediciNova Market Cap
MediciNova has a market cap or net worth of $69.89 million as of April 2, 2026. Its market cap has decreased by -5.04% in one year.
Market Cap
69.89M
Enterprise Value
38.81M
1-Year Change
-5.04%
Ranking
Category
Stock Price
$1.42
Market Cap Chart
Since December 8, 2006, MediciNova's market cap has decreased from $124.80M to $69.89M, a decrease of -44.00%. That is a compound annual growth rate of -2.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 69.90M | 8.71% |
| Dec 31, 2025 | 64.30M | -37.57% |
| Dec 31, 2024 | 103.00M | 39.95% |
| Dec 29, 2023 | 73.60M | -26.77% |
| Dec 30, 2022 | 100.50M | -23.52% |
| Dec 31, 2021 | 131.40M | -44.39% |
| Dec 31, 2020 | 236.30M | -20.03% |
| Dec 31, 2019 | 295.50M | -13.65% |
| Dec 31, 2018 | 342.20M | 46.49% |
| Dec 29, 2017 | 233.60M | 12.31% |
| Dec 30, 2016 | 208.00M | 95.67% |
| Dec 31, 2015 | 106.30M | 44.43% |
| Dec 31, 2014 | 73.60M | 53.65% |
| Dec 31, 2013 | 47.90M | 69.86% |
| Dec 31, 2012 | 28.20M | 3.30% |
| Dec 30, 2011 | 27.30M | -53.41% |
| Dec 31, 2010 | 58.60M | -31.22% |
| Dec 31, 2009 | 85.20M | 346.07% |
| Dec 31, 2008 | 19.10M | -65.27% |
| Dec 31, 2007 | 55.00M | -59.85% |
| Dec 29, 2006 | 137.00M | 9.78% |
| Dec 8, 2006 | 124.80M | - |
View and export this data all the way back to 2006. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pelthos Therapeutics | 70.50M |
| Dogwood Therapeutics | 70.48M |
| NRx Pharmaceuticals | 70.36M |
| Coeptis Therapeutics Holdings | 69.82M |
| Cognition Therapeutics | 67.86M |
| Alterity Therapeutics | 67.18M |
| PMV Pharmaceuticals | 66.13M |
| iBio, Inc. | 65.63M |